Navigation Links
ConvaTec Presents New Data on ConvaTec Moldable Technology™ and Vitala™ Continence Control Device in Ostomy Care
Date:6/7/2011

SKILLMAN, N.J., June 7, 2011 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today presented new data from multiple studies related to its advanced technologies in ostomy care including ConvaTec Moldable Technology™ and the Vitala™ Continence Control Device (CCD).  Results were presented at the Wound, Ostomy and Continence Nurses Society (WOCN) 43rd Annual Conference held June 4-8, 2011 in New Orleans, LA.

ConvaTec Moldable Technology™ Skin Barriers ConvaTec Moldable Technology™ Skin Barriers with Rebounding Memory Technology™ are the only skin barriers with a patented* tri-laminate construction that actively adjusts to the shape and contours of the stoma. ConvaTec Moldable Technology™ Skin Barriers are also backed by extensive clinical experience demonstrating their ability to prevent leaks and protect the peristomal skin.(1,2)  ConvaTec presented five abstracts on patient and heath care provider experiences with Moldable Technology™:  

  • A Survey of Quality of Life Measures in Patients Who Have Transitioned from Using a Non-Moldable Skin Barrier to a Moldable Skin Barrier (Abstract # 5452)

  • Skin Barrier Selection in an Outpatient Ostomy Clinic (Abstract # 5250)

  • The Perfect Fit: Moldable Technology in Home Care (Abstract # 5217)

  • The Road to Independence: Successful Use of Moldable Ostomy Skin Barriers to Improve Patient Outcomes (Abstract # 5137)

  • Use of a Moldable Skin Barrier with Adhesive Coupling to Manage Severely Denuded Peristomal Skin (Abstract # 5251)

  • Vitala™ Continence Control Device (CCD)Data was also presented data on the Vitala™ CCD, an innovative, non-invasive device that restores continence for up to 12 hours per day, allowing patients to manage their colostomy without having to wear a pouch or incorporate irrigation. The unique design also helps to reduce odor and noise.(3) Four prospective case studies of patient experiences with Vitala™ CCD drawn from the device's Phase 3 clinical trial(4) were presented as an abstract and poster titled:  

  • Patient and WOC Nurse Assessment of a Novel Continence Control Device (CCD): Stoma Management, Quality of Life and Productivity (Abstract # 5154)

  • "For more than 30 years, ConvaTec has been committed to meeting the needs of people living with an ostomy through breakthrough solutions in medical technology. Each of our products is developed based on health care provider and patient feedback in order to provide genuine benefits to patients and their health care teams. Our focus is on advancing technologies that can offer unparalleled security and ease of use to empower patients in their recovery from this life-changing surgery," said Brad Barton, President, ConvaTec USA.

    Vitala™ CCD is currently available in the Netherlands, Czech Republic and United Kingdom, and is soon to be launched in additional European markets.

    About ConvaTecConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas – Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices – ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit www.convatec.com.

    ConvaTec Moldable Technology, Rebounded Memory Technology and Vitala are registered trademarks of ConvaTec Inc. * U.S. Patent No. 6,840,924 B2© 2011 ConvaTec Inc.

    SC-000245-USContactsPunnie DonohueAndrea CoanConvaTec

    Berry & Company Public Relations908-904-2151

    212-253-8881Punnie.donohue@convatec.com

    acoan@berrypr.com(1) Scott V, Raasch D, Kennedy G, Heise C. Prospective assessment and classification of stoma related skin disorders. Poster presented at: 41st Annual Wound Ostomy and Continence Nurses Society Conference; June 6-10, 2009; Orlando, Florida(2) Hoeflok J, Guy D, Allen S, St-Cry D. A prospective multicenter evaluation of a moldable stoma skin barrier. Ostomy Wound Manage. 2009;55(5):62-69.(3) Multinational Phase III Vitala™ CCD 12-Hour Wear Test. CC-0196-08-A720. June 18, 2010, Data on file, ConvaTec Inc.(4) CC 0196-10-A725 Final Study Report
    '/>"/>

    SOURCE ConvaTec
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. New Data Supports ConvaTec Negative Pressure Wound Therapy
    2. ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing
    3. ConvaTec to Present at AdvaMed 2010: The MedTech Conference
    4. Bradford Barton Named President, ConvaTec U.S.
    5. ConvaTec Healthcare Announces Senior Secured Notes Offering & Senior Notes Offering
    6. ConvaTec Announces New Appointments to Leadership Team
    7. ConvaTec Announces New Appointment to Leadership Team
    8. ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans
    9. ConvaTec Healthcare Postpones Plans To Refinance Secured Term Loans
    10. Holy Family Medical Center Selects ConvaTec Negative Pressure for Wound Care
    11. ConvaTec Supported Studies to be Presented at the 24th Annual Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
    (Date:4/19/2017)... Tenn. and DALLAS , April 19, 2017 ... announced that the first patients in Nashville ... device in the Lower Esophageal Sphincter Stimulation for GERD ... implantable device designed to provide long-term reflux control by ... GERD affects nearly 65 million people in ...
    (Date:4/19/2017)... LONDON , April 19, 2017 ... to stimulate an immune response in pets such ... vaccine products are of various types such as ... Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. ... such as virus or bacteria, which have been ...
    Breaking Medicine Technology:
    (Date:4/30/2017)... Viejo, CA (PRWEB) , ... April 30, 2017 ... ... animations created exclusively for use in Final Cut Pro X. Editors can pick ... and more. Easily change the highlights, mid levels and shadows using simple color ...
    (Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set of ... video to the next without having to set a single keyframe in Final ... enhance your video production. , TransDark features dynamic transitions that momentarily splits the RGB ...
    (Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty ... pounds with the help of a weight loss surgery. The woman, declaring “I will not ... have been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while ...
    (Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
    (Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly introduces ... an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and programmed-start ... 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and maintenance ...
    Breaking Medicine News(10 mins):